| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Departments of 1 Radiology, 2 Pathology, 3 Pharmacology and Cancer Biology, and 4 Radiation Oncology, Duke University Medical Center, Durham, North Carolina
Requests for reprints: Edward F. Patz, Jr., Department of Radiology, Duke University Medical Center, Box 3808, Durham, NC 27710. Phone: 919-684-7311; Fax: 919-684-7165; E-mail: patz0002{at}mc.duke.edu.
Cyclophilin A (CypA) was recently reported to be overexpressed in non–small-cell lung cancer, and represents a potentially novel therapeutic target. To determine the role of CypA in oncogenesis, stable RNA interference (RNAi)–mediated knockdown of CypA was established in two non–small-cell lung cancer cell lines (ADLC-5M2 and LC-103H), and these cells were grown as xenografts in severe combined immunodeficient mice. Tumor cell proliferation, apoptosis, and angiogenesis were measured by Ki67, terminal deoxyribonucleotidyl transferase–mediated dUTP nick-end labeling, and CD31 immunohistochemistry, respectively. Tumor glucose metabolism was assessed by fluorodeoxyglucose positron emission tomography imaging. Knockdown of CypA correlated in vivo with slower growth, less fluorodeoxyglucose uptake, decreased proliferation, and a greater degree of apoptosis in the tumors. These results establish the relevance of CypA to tumor growth in vivo, specifically to proliferation and apoptosis. Elucidation of the precise role of CypA in these pathways may lead to new targeted therapies for lung cancer.
This article has been cited by other articles:
|
|
 |
|
  C. Desmetz, C. Bascoul-Mollevi, P. Rochaix, P.-J. Lamy, A. Kramar, P. Rouanet, T. Maudelonde, A. Mange, and J. Solassol Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women Clin. Cancer Res., July 15, 2009; 15(14): 4733 - 4741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. T. Bane, J. H. Bannon, S. R. Pennington, G. Campaini, D. C. Williams, D. M. Zisterer, and M. M. Mc Gee The Microtubule-Targeting Agents, PBOX-6 [Pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and Paclitaxel, Induce Nucleocytoplasmic Redistribution of the Peptidyl-Prolyl Isomerases, Cyclophilin A and Pin1, in Malignant Hematopoietic Cells J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 38 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, X. Zhao, S. Bai, Z. Wang, L. Chen, Y. Wei, and C. Huang Proteomics Identification of Cyclophilin A as a Potential Prognostic Factor and Therapeutic Target in Endometrial Carcinoma Mol. Cell. Proteomics, October 1, 2008; 7(10): 1810 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chaurand, M. A. Rahman, T. Hunt, J. A. Mobley, G. Gu, J. C. Latham, R. M. Caprioli, and S. Kasper Monitoring Mouse Prostate Development by Profiling and Imaging Mass Spectrometry Mol. Cell. Proteomics, February 1, 2008; 7(2): 411 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Choi, Y. J. Piao, M. J. Lim, J. H. Kim, J. Ha, W. Choe, and S. S. Kim Overexpressed Cyclophilin A in Cancer Cells Renders Resistance to Hypoxia- and Cisplatin-Induced Cell Death Cancer Res., April 15, 2007; 67(8): 3654 - 3662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Semba and K. Huebner Protein Expression Profiling Identifies Cyclophilin A as a Molecular Target in Fhit-Mediated Tumor Suppression Mol. Cancer Res., August 1, 2006; 4(8): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
